...
首页> 外文期刊>Journal of the Chemical Society, Perkin Transactions 1 >Synthesis and serotonergic activity of 2-oxadiazolyl-5-substituted-N, N-dimethyltryptamines: novel antagonists for the vascular 5-HT_(1B)-like receptor
【24h】

Synthesis and serotonergic activity of 2-oxadiazolyl-5-substituted-N, N-dimethyltryptamines: novel antagonists for the vascular 5-HT_(1B)-like receptor

机译:2-恶二唑基-5-取代的N,N-二甲基色胺的合成及其血清素能活性:血管5-HT_(1B)样受体的新型拮抗剂

获取原文
获取原文并翻译 | 示例

摘要

The synthesis and vascular 5-HT_(1B)-like receptor activity of a novel series of 2-oxadiazolyl-t-substituted tryptamine derivatives 2 is described. Modifications to the 2-oxadiazolyl group R~1, the heterocycle R~2 and the length of the linking chain (n) have been explored. Several compounds were identified which exhibited moderate 5-HT_(1B)-like receptor affinity. In particualr, 2-(3-ethyl-1, 2, 4-oxadiazol-5-yl)-3-[2-(dimethylamino)ethyl]-5-[(4, 4-dimethyl-2, 5-dioxoimidazolidin-1-yl)methyl]-1H-indole (20) in which n = 1 had a pK_B = 7.23 at the 5-HT_(1B)-like receptor and > 60 fold selectivity over #alpha#_1-adrenoceptor affinity. This contrasts with the higher homologue derivatives such as 10 and 11 where n = 2 which exhibited decreased potency and selectivity for the 5-HT_(1B)-like receptor. The 2-oxadiazolyl-5-substituted-N, N-dimethyltryptamine derivatives were found to be silent (as judged by the inability of angiotensin II to unmask 5-HT_(1B)-like receptor mediated agonist activity in the rabbit femoral artery) and competitive 5-HT_(1B)-like receptor antagonists with half lives of up to 1.5 hours in dog plasma and with good oral bioavailability.
机译:描述了一系列新的2-恶二唑基-t-取代的色胺衍生物2的合成和血管内5-HT_(1B)样受体活性。已经研究了对2-恶二唑基R-1,杂环R-2和连接链长度(n)的修饰。鉴定出几种化合物,它们表现出中等的5-HT_(1B)-样受体亲和力。特别是2-(3-乙基-1,2,2,4-恶二唑-5-基)-3- [2-(二甲基氨基)乙基] -5-[(4,4-二甲基-2,5-二氧杂咪唑啉- n = 1的1-yl)甲基] -1H-吲哚(20)在5-HT_(1B)样受体处的pK_B = 7.23,选择性是#alpha#_1-肾上腺素受体亲和力的60倍以上。这与较高的同源衍生物如10和11相反,其中n = 2,其对5-HT_(1B)样受体显示出降低的效力和选择性。发现2-恶二唑基-5-取代的N,N-二甲基色胺衍生物是沉默的(通过血管紧张素II不能掩盖兔股动脉中5-HT_(1B)样受体介导的激动剂活性来判断)和具有竞争性的5-HT_(1B)样受体拮抗剂,在狗血浆中的半衰期长达1.5小时,并且具有良好的口服生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号